{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:43:09Z","timestamp":1790718189618,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/pr.2017.249","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T16:00:26Z","timestamp":1507046426000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders"],"prefix":"10.1038","volume":"83","author":[{"given":"Won Soon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se In","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Yin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Sil","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"BFpr2017249_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000087581","volume":"88","author":"RD Bland","year":"2005","unstructured":"Bland RD . Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005;88:181\u201391.","journal-title":"Biol Neonate"},{"key":"BFpr2017249_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.semperi.2006.05.009","volume":"30","author":"A Bhandari","year":"2006","unstructured":"Bhandari A, Panitch HB . Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006;30:219\u201326.","journal-title":"Semin Perinatol"},{"key":"BFpr2017249_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1542\/peds.105.6.1216","volume":"105","author":"BR Vohr","year":"2000","unstructured":"Vohr BR, Wright LL, Dusick AM et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993\u20131994. Pediatrics 2000;105:1216\u201326.","journal-title":"Pediatrics"},{"key":"BFpr2017249_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0387-7604(96)00561-X","volume":"19","author":"MV Johnston","year":"1997","unstructured":"Johnston MV . Hypoxic and ischemic disorders of infants and children. Lecture for 38th meeting of Japanese Society of Child Neurology, Tokyo, Japan, July 1996. Brain Dev 1997;19:235\u20139.","journal-title":"Brain Dev"},{"key":"BFpr2017249_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3727\/096368909X471189","volume":"18","author":"YS Chang","year":"2009","unstructured":"Chang YS, Oh W, Choi SJ et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2009;18:869\u2013886.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR6","doi-asserted-by":"publisher","first-page":"e52419","DOI":"10.1371\/journal.pone.0052419","volume":"8","author":"YS Chang","year":"2013","unstructured":"Chang YS, Choi SJ, Ahn SY et al. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS ONE 2013;8:e52419.","journal-title":"PLoS ONE"},{"key":"BFpr2017249_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","volume":"51","author":"YS Chang","year":"2014","unstructured":"Chang YS, Ahn SY, Jeon HB et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol 2014;51:391\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFpr2017249_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3349\/ymj.2013.54.2.416","volume":"54","author":"SY Ahn","year":"2013","unstructured":"Ahn SY, Chang YS, Kim SY et al. Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury. Yonsei Med J 2013;54:416\u201324.","journal-title":"Yonsei Med J"},{"key":"BFpr2017249_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3346\/jkms.2015.30.5.509","volume":"30","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Chang YS, Park WS . Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation. J Korean Med Sci 2015;30:509\u201313.","journal-title":"J Korean Med Sci"},{"key":"BFpr2017249_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcyt.2015.03.008","volume":"17","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Chang YS, Sung DK et al. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy 2015;17:1025\u201335.","journal-title":"Cytotherapy"},{"key":"BFpr2017249_CR11","doi-asserted-by":"publisher","first-page":"e0135574","DOI":"10.1371\/journal.pone.0135574","volume":"10","author":"DK Sung","year":"2015","unstructured":"Sung DK, Chang YS, Ahn SY et al. Optimal route for human umbilical cord blood-derived mesenchymal stem cell transplantation to protect against neonatal hyperoxic lung injury: gene expression profiles and histopathology. PLoS ONE 2015;10:e0135574.","journal-title":"PLoS ONE"},{"key":"BFpr2017249_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3345\/kjp.2014.57.6.251","volume":"57","author":"SY Ahn","year":"2014","unstructured":"Ahn SY, Chang YS, Park WS . Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J Pediatr 2014;57:251\u20136.","journal-title":"Korean J Pediatr"},{"key":"BFpr2017249_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3727\/096368916X692861","volume":"26","author":"SY Ahn","year":"2016","unstructured":"Ahn SY, Chang YS, Sung DK, Sung SI, Ahn JY, Park WS . Pivotal role of brain derived neurotrophic factor secreted by mesenchymal stem cells in severe intraventricular hemorrhage in the newborn rats. Cell Transplant 2016;26:145\u2013156.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR14","doi-asserted-by":"publisher","first-page":"e0132919","DOI":"10.1371\/journal.pone.0132919","volume":"10","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Chang YS, Sung DK et al. Optimal route for mesenchymal stem cells transplantation after severe intraventricular hemorrhage in newborn rats. PLoS ONE 2015;10:e0132919.","journal-title":"PLoS ONE"},{"key":"BFpr2017249_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","volume":"44","author":"SY Ahn","year":"2013","unstructured":"Ahn SY, Chang YS, Sung DK et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 2013;44:497\u2013504.","journal-title":"Stroke"},{"key":"BFpr2017249_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang YS, Ahn SY, Yoo HS et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr 2014;164:966\u201372 e6.","journal-title":"J Pediatr"},{"key":"BFpr2017249_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten CM, Murtha AP, Goldberg RN et al. Feasibility of autologous cord blood cells for infants with hypoxic\u2013ischemic encephalopathy. J Pediatr 2014;164:973\u20139 e1.","journal-title":"J Pediatr"},{"key":"BFpr2017249_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12079-013-0190-x","volume":"7","author":"AP Popova","year":"2013","unstructured":"Popova AP . Mechanisms of bronchopulmonary dysplasia. J Cell Commun Signal 2013;7:119\u201327.","journal-title":"J Cell Commun Signal"},{"key":"BFpr2017249_CR19","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2017249_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev.physiol.67.040403.102229","volume":"67","author":"KR Stenmark","year":"2005","unstructured":"Stenmark KR, Abman SH . Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005;67:623\u201361.","journal-title":"Annu Rev Physiol"},{"key":"BFpr2017249_CR21","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMra067279","volume":"357","author":"E Baraldi","year":"2007","unstructured":"Baraldi E, Filippone M . Chronic lung disease after premature birth. N Engl J Med 2007;357:1946\u201355.","journal-title":"N Engl J Med"},{"key":"BFpr2017249_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1203\/PDR.0b013e3181c1b176","volume":"67","author":"P Ballabh","year":"2010","unstructured":"Ballabh P . Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1\u20138.","journal-title":"Pediatr Res"},{"key":"BFpr2017249_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clp.2013.09.007","volume":"41","author":"P Ballabh","year":"2014","unstructured":"Ballabh P . Pathogenesis and prevention of intraventricular hemorrhage. Clin Perinatol 2014;41:47\u201367.","journal-title":"Clin Perinatol"},{"key":"BFpr2017249_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1179\/016164105X25216","volume":"27","author":"JW Calvert","year":"2005","unstructured":"Calvert JW, Zhang JH . Pathophysiology of an hypoxic\u2013ischemic insult during the perinatal period. Neurol Res 2005;27:246\u201360.","journal-title":"Neurol Res"},{"key":"BFpr2017249_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fneur.2014.00147","volume":"5","author":"GS Gonzales-Portillo","year":"2014","unstructured":"Gonzales-Portillo GS, Reyes S, Aguirre D, Pabon MM, Borlongan CV . Stem cell therapy for neonatal hypoxic\u2013ischemic encephalopathy. Front Neurol 2014;5:147.","journal-title":"Front Neurol"},{"key":"BFpr2017249_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/scd.2009.0403","volume":"19","author":"PM Pimentel-Coelho","year":"2010","unstructured":"Pimentel-Coelho PM, Mendez-Otero R . Cell therapy for neonatal hypoxic\u2013ischemic encephalopathy. Stem Cells Dev 2010;19:299\u2013310.","journal-title":"Stem Cells Dev"},{"key":"BFpr2017249_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1465-9921-12-108","volume":"12","author":"ES Kim","year":"2011","unstructured":"Kim ES, Chang YS, Choi SJ et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir Res 2011;12:108.","journal-title":"Respir Res"},{"key":"BFpr2017249_CR28","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/hep.22236","volume":"47","author":"D van Poll","year":"2008","unstructured":"van Poll D, Parekkadan B, Cho CH et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634\u201343.","journal-title":"Hepatology"},{"key":"BFpr2017249_CR29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbi.2011.03.021","volume":"25","author":"CT van Velthoven","year":"2011","unstructured":"van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ . Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 2011;25:1342\u20138.","journal-title":"Brain Behav Immun"},{"key":"BFpr2017249_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.bbrc.2009.10.058","volume":"390","author":"D Zisa","year":"2009","unstructured":"Zisa D, Shabbir A, Suzuki G, Lee T . Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun 2009;390:834\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFpr2017249_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1164\/rccm.200909-1330ED","volume":"180","author":"SH Abman","year":"2009","unstructured":"Abman SH, Matthay MA . Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia: delivering the secretome. Am J Respir Crit Care Med 2009;180:1039\u201341.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2017249_CR32","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1681\/ASN.2005080815","volume":"17","author":"U Kunter","year":"2006","unstructured":"Kunter U, Rong S, Djuric Z et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006;17:2202\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"BFpr2017249_CR33","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755\u201361.","journal-title":"Blood"},{"key":"BFpr2017249_CR34","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"LA Ortiz","year":"2003","unstructured":"Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017249_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3727\/096368916X694193","volume":"26","author":"WS Park","year":"2017","unstructured":"Park WS, Ahn SY, Sung SI, Ahn JY, Chang YS,. Mesenchymal stem cells: the magic cure for intraventricular hemorrhage? Cell Transplant 2017;26:439\u201348.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-7091-0693-8_10","volume":"111","author":"T Lekic","year":"2011","unstructured":"Lekic T, Manaenko A, Rolland W, Tang J, Zhang JH . A novel preclinical model of germinal matrix hemorrhage using neonatal rats. Acta Neurochir Suppl 2011;111:55\u201360.","journal-title":"Acta Neurochir Suppl"},{"key":"BFpr2017249_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4161\/org.7.2.16605","volume":"7","author":"B Bussolati","year":"2011","unstructured":"Bussolati B . Stem cells for organ repair: support or replace? Organogenesis 2011;7:95.","journal-title":"Organogenesis"},{"key":"BFpr2017249_CR38","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/dvdy.21258","volume":"236","author":"F Togel","year":"2007","unstructured":"Togel F, Westenfelder C . Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007;236:3321\u201331.","journal-title":"Dev Dyn"},{"key":"BFpr2017249_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2133.1990.tb01483.x","volume":"123","author":"KM Godfrey","year":"1990","unstructured":"Godfrey KM, James MP . Treatment of severe acne with isotretinoin in patients with inflammatory bowel disease. Br J Dermatol 1990;123:653\u20135.","journal-title":"Br J Dermatol"},{"key":"BFpr2017249_CR40","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1371\/journal.pone.0000941","volume":"2","author":"B Parekkadan","year":"2007","unstructured":"Parekkadan B, van Poll D, Suganuma K et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007;2:e941.","journal-title":"PLoS One"},{"key":"BFpr2017249_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","volume":"68","author":"M Pierro","year":"2012","unstructured":"Pierro M, Ionescu L, Montemurro T et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2012;68:475\u201384.","journal-title":"Thorax"},{"key":"BFpr2017249_CR42","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","volume":"180","author":"M Aslam","year":"2009","unstructured":"Aslam M, Baveja R, Liang OD et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009;180:1122\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2017249_CR43","doi-asserted-by":"publisher","first-page":"L967","DOI":"10.1152\/ajplung.00144.2011","volume":"303","author":"L Ionescu","year":"2012","unstructured":"Ionescu L, Byrne RN, van Haaften T et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 2012;303:L967\u201377.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFpr2017249_CR44","doi-asserted-by":"publisher","first-page":"448 e8","DOI":"10.1016\/j.ajog.2012.02.038","volume":"206","author":"RJ Hodges","year":"2012","unstructured":"Hodges RJ, Jenkin G, Hooper SB et al. Human amnion epithelial cells reduce ventilation-induced preterm lung injury in fetal sheep. Am J Obstet Gynecol 2012;206:448 e8\u201315.","journal-title":"Am J Obstet Gynecol"},{"key":"BFpr2017249_CR45","doi-asserted-by":"publisher","first-page":"156 e26","DOI":"10.1016\/j.ajog.2011.03.054","volume":"205","author":"P Vosdoganes","year":"2011","unstructured":"Vosdoganes P, Hodges RJ, Lim R et al. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol 2011;205:156 e26\u201333.","journal-title":"Am J Obstet Gynecol"},{"key":"BFpr2017249_CR46","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838\u201343.","journal-title":"Blood"},{"key":"BFpr2017249_CR47","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","volume":"179","author":"N Gupta","year":"2007","unstructured":"Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA . Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007;179:1855\u201363.","journal-title":"J Immunol"},{"key":"BFpr2017249_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","volume":"51","author":"YS Chang","year":"2014","unstructured":"Chang YS, Ahn SY, Jeon HB et al. Critical role of VEGF secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol 2014;51:391\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFpr2017249_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/scd.2009.0495","volume":"20","author":"Y Chen","year":"2011","unstructured":"Chen Y, Qian H, Zhu W et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 2011;20:103\u201313.","journal-title":"Stem Cells Dev"},{"key":"BFpr2017249_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/thoraxjnl-2011-201059","volume":"67","author":"GF Curley","year":"2012","unstructured":"Curley GF, Hayes M, Ansari B et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012;67:496\u2013501.","journal-title":"Thorax"},{"key":"BFpr2017249_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/089771504772695922","volume":"21","author":"A Mahmood","year":"2004","unstructured":"Mahmood A, Lu D, Chopp M . Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 2004;21:33\u20139.","journal-title":"J Neurotrauma"},{"key":"BFpr2017249_CR52","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1681\/ASN.2006121318","volume":"18","author":"B Imberti","year":"2007","unstructured":"Imberti B, Morigi M, Tomasoni S et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007;18:2921\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"BFpr2017249_CR53","doi-asserted-by":"publisher","first-page":"26211","DOI":"10.1074\/jbc.M110.119917","volume":"285","author":"X Fang","year":"2010","unstructured":"Fang X, Neyrinck AP, Matthay MA, Lee JW . Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 2010;285:26211\u201322.","journal-title":"J Biol Chem"},{"key":"BFpr2017249_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/scrt68","volume":"2","author":"S Danchuk","year":"2011","unstructured":"Danchuk S, Ylostalo JH, Hossain F et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011;2:27.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017249_CR55","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1073\/pnas.0704421104","volume":"104","author":"LA Ortiz","year":"2007","unstructured":"Ortiz LA, Dutreil M, Fattman C et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007;104:11002\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2017249_CR56","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/thoraxjnl-2011-201176","volume":"67","author":"N Gupta","year":"2012","unstructured":"Gupta N, Krasnodembskaya A, Kapetanaki M et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax 2012;67:533\u20139.","journal-title":"Thorax"},{"key":"BFpr2017249_CR57","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/stem.544","volume":"28","author":"A Krasnodembskaya","year":"2010","unstructured":"Krasnodembskaya A, Song Y, Fang X et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010;28:2229\u201338.","journal-title":"Stem Cells"},{"key":"BFpr2017249_CR58","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/cmi.12522","volume":"18","author":"DK Sung","year":"2016","unstructured":"Sung DK, Chang YS, Sung SI, Yoo HS, Ahn SY, Park WS . Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin- 2 via toll- like receptor 4 signalling. Cell Microbiol 2016;18:424\u201336.","journal-title":"Cell Microbiol"},{"key":"BFpr2017249_CR59","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4049\/jimmunol.1500244","volume":"195","author":"X Fang","year":"2015","unstructured":"Fang X, Abbott J, Cheng L et al. Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. J Immunol 2015;195:875\u201381.","journal-title":"J Immunol"},{"key":"BFpr2017249_CR60","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1097\/CCM.0000000000001999","volume":"44","author":"K Tsoyi","year":"2016","unstructured":"Tsoyi K, Hall SR, Dalli J et al. Carbon monoxide improves efficacy of mesenchymal stromal cells during sepsis by production of specialized proresolving lipid mediators. Crit Care Med 2016;44:e1236\u2013e45.","journal-title":"Crit Care Med"},{"key":"BFpr2017249_CR61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/glia.22500","volume":"61","author":"S Pluchino","year":"2013","unstructured":"Pluchino S, Cossetti C . How stem cells speak with host immune cells in inflammatory brain diseases. Glia 2013;61:1379\u2013401.","journal-title":"Glia"},{"key":"BFpr2017249_CR62","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1089\/ars.2013.5784","volume":"21","author":"K Sdrimas","year":"2014","unstructured":"Sdrimas K, Kourembanas S . MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal 2014;21:1905\u201315.","journal-title":"Antioxid Redox Signal"},{"key":"BFpr2017249_CR63","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","volume":"126","author":"C Lee","year":"2012","unstructured":"Lee C, Mitsialis SA, Aslam M et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012;126:2601\u201311.","journal-title":"Circulation"},{"key":"BFpr2017249_CR64","doi-asserted-by":"publisher","first-page":"754","DOI":"10.5966\/sctm.2015-0197","volume":"5","author":"DR Ophelders","year":"2016","unstructured":"Ophelders DR, Wolfs TG, Jellema RK et al. Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia\u2013ischemia. Stem Cells Transl Med 2016;5:754\u201363.","journal-title":"Stem Cells Transl Med"},{"key":"BFpr2017249_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.imlet.2012.06.001","volume":"147","author":"A Mokarizadeh","year":"2012","unstructured":"Mokarizadeh A, Delirezh N, Morshedi A, Mosayebi G, Farshid AA, Mardani K . Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 2012;147:47\u201354.","journal-title":"Immunol Lett"},{"key":"BFpr2017249_CR66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/scrt194","volume":"4","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Xu H, Xu W et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013;4:34.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017249_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","volume":"182","author":"B Yu","year":"2015","unstructured":"Yu B, Kim HW, Gong M et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 2015;182:349\u201360.","journal-title":"Int J Cardiol"},{"key":"BFpr2017249_CR68","doi-asserted-by":"crossref","unstructured":"Willis GR, Fernandez-Gonzalez A, Anastas J et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am J Respir Crit Care Med 2017 (e-pub ahead of print).","DOI":"10.1164\/rccm.201705-0925OC"},{"key":"BFpr2017249_CR69","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jpedsurg.2016.02.061","volume":"51","author":"TM Rager","year":"2016","unstructured":"Rager TM, Olson JK, Zhou Y, Wang Y, Besner GE . Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis. J Pediatr Surg 2016;51:942\u20137.","journal-title":"J Pediatr Surg"},{"key":"BFpr2017249_CR70","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1089\/hum.2015.072","volume":"26","author":"N Heldring","year":"2015","unstructured":"Heldring N, Mager I, Wood MJ, Le Blanc K, Andaloussi SE . Therapeutic potential of multipotent mesenchymal stromal cells and their extracellular vesicles. Hum Gene Ther 2015;26:506\u201317.","journal-title":"Hum Gene Ther"},{"key":"BFpr2017249_CR71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13287-015-0214-y","volume":"6","author":"T Katsuda","year":"2015","unstructured":"Katsuda T, Ochiya T . Molecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repair. Stem Cell Res Ther 2015;6:212.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017249_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-physiol-021014-071641","volume":"77","author":"S Kourembanas","year":"2015","unstructured":"Kourembanas S . Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 2015;77:13\u201327.","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"BFpr2017249_CR73","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ijms18071450","volume":"18","author":"Verena B\u00f6rger","year":"2017","unstructured":"Borger V, Bremer M, Ferrer-Tur R et al. Mesenchymal stem\/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci 2017;18.","journal-title":"International Journal of Molecular Sciences"},{"key":"BFpr2017249_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40635-015-0065-y","volume":"3","author":"M Hayes","year":"2015","unstructured":"Hayes M, Curley GF, Masterson C, Devaney J, O'Toole D, Laffey JG . Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury. Intens Care Med Exp 2015;3:29.","journal-title":"Intens Care Med Exp"},{"key":"BFpr2017249_CR75","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012;18:759\u201365.","journal-title":"Nat Med"},{"key":"BFpr2017249_CR76","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1165\/rcmb.2013-0529OC","volume":"51","author":"X Li","year":"2014","unstructured":"Li X, Zhang Y, Yeung SC et al. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol 2014;51:455\u201365.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFpr2017249_CR77","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"MV Jackson","year":"2016","unstructured":"Jackson MV, Morrison TJ, Doherty DF et al. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 2016;34:2210\u201323.","journal-title":"Stem Cells"},{"key":"BFpr2017249_CR78","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1038\/ncomms9472","volume":"6","author":"DG Phinney","year":"2015","unstructured":"Phinney DG, Di Giuseppe M, Njah J et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015;6:8472.","journal-title":"Nat Commun"},{"key":"BFpr2017249_CR79","doi-asserted-by":"crossref","unstructured":"Morrison TJ, Jackson MV, Cunningham EK et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 2017 (e-pub ahead of print).","DOI":"10.1164\/rccm.201701-0170OC"},{"key":"BFpr2017249_CR80","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM . Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 2014;32:252\u201360.","journal-title":"Nat Biotechnol"},{"key":"BFpr2017249_CR81","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.semperi.2015.12.002","volume":"40","author":"SA Mitsialis","year":"2016","unstructured":"Mitsialis SA, Kourembanas S . Stem cell-based therapies for the newborn lung and brain: possibilities and challenges. Semin Perinatol 2016;40:138\u201351.","journal-title":"Semin Perinatol"},{"key":"BFpr2017249_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/ten.teb.2011.0488","volume":"18","author":"J Doorn","year":"2012","unstructured":"Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J . Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 2012;18:101\u201315.","journal-title":"Tissue Eng Part B Rev"},{"key":"BFpr2017249_CR83","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.pmr.2016.06.004","volume":"27","author":"KA Hasty","year":"2016","unstructured":"Hasty KA, Cho H . Stem cell considerations for the clinician. Phys Med Rehabil Clin N Am 2016;27:855\u201370.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"BFpr2017249_CR84","first-page":"54","volume":"24","author":"M Mueller","year":"2016","unstructured":"Mueller M, Kramer BW . Stem cells and bronchopulmonary dysplasia\u2014the five questions: which cells, when, in which dose, to which patients via which route? Paediatr Respir Rev 2016;24:54\u201359.","journal-title":"Paediatr Respir Rev"},{"key":"BFpr2017249_CR85","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1111\/j.1582-4934.2010.01151.x","volume":"14","author":"DJ Prockop","year":"2010","unstructured":"Prockop DJ, Kota DJ, Bazhanov N, Reger RL . Evolving paradigms for repair of tissues by adult stem\/progenitor cells (MSCs). J Cell Mol Med 2010;14:2190\u20139.","journal-title":"J Cell Mol Med"},{"key":"BFpr2017249_CR86","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI . Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013;45:e54.","journal-title":"Exp Mol Med"},{"key":"BFpr2017249_CR87","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcp.25255","volume":"231","author":"AI Caplan","year":"2016","unstructured":"Caplan AI . MSCs: the sentinel and safe-guards of injury. J Cell Physiol 2016;231:1413\u20136.","journal-title":"J Cell Physiol"},{"key":"BFpr2017249_CR88","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM . A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE 2010;5:e10088.","journal-title":"PLoS ONE"},{"key":"BFpr2017249_CR89","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE . Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 2013;13:392\u2013402.","journal-title":"Cell Stem Cell"},{"key":"BFpr2017249_CR90","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2217\/imt.12.41","volume":"4","author":"JJ Auletta","year":"2012","unstructured":"Auletta JJ, Bartholomew AM, Maziarz RT et al. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy 2012;4:529\u201347.","journal-title":"Immunotherapy"},{"key":"BFpr2017249_CR91","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/leu.2014.127","volume":"28","author":"A Balan","year":"2014","unstructured":"Balan A, Lucchini G, Schmidt S et al. Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease\u2014friends or foes? Leukemia 2014;28:1941\u20138.","journal-title":"Leukemia"},{"key":"BFpr2017249_CR92","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/pr.2011.64","volume":"71","author":"CT van Velthoven","year":"2012","unstructured":"van Velthoven CT, Kavelaars A, Heijnen CJ . Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 2012;71:474\u201381.","journal-title":"Pediatr Res"},{"key":"BFpr2017249_CR93","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan AI . Mesenchymal stem cells: time to change the name!. Stem Cells Transl Med 2017;6:1445\u201351.","journal-title":"Stem Cells Transl Med"},{"key":"BFpr2017249_CR94","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3349\/ymj.2017.58.2.266","volume":"58","author":"YS Chang","year":"2017","unstructured":"Chang YS, Ahn SY, Sung S, Park WS . Stem cell therapy for neonatal disorders: prospects and challenges. Yonsei Med J 2017;58:266\u201371.","journal-title":"Yonsei Med J"},{"key":"BFpr2017249_CR95","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000444905","volume":"109","author":"SY Ahn","year":"2016","unstructured":"Ahn SY, Chang YS, Park WS . Stem cells for neonatal brain disorders. Neonatology 2016;109:377\u201383.","journal-title":"Neonatology"},{"key":"BFpr2017249_CR96","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"BFpr2017249_CR97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, Bohm S, Jacobs R . Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011;9:12.","journal-title":"Cell Commun Signal"},{"key":"BFpr2017249_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","volume":"14","author":"M Mendicino","year":"2014","unstructured":"Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR . MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 2014;14:141\u20135.","journal-title":"Cell Stem Cell"},{"key":"BFpr2017249_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143\u20137.","journal-title":"Science"},{"key":"BFpr2017249_CR100","first-page":"50","volume":"2","author":"S Pacini","year":"2014","unstructured":"Pacini S . Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs). Front Cell Dev Biol 2014;2:50.","journal-title":"Front Cell Dev Biol"},{"key":"BFpr2017249_CR101","first-page":"50","volume":"2","author":"MA Mobius","year":"2015","unstructured":"Mobius MA, Thebaud B . Stem cells and their mediators\u2014next generation therapy for bronchopulmonary dysplasia. Front Med (Lausanne) 2015;2:50.","journal-title":"Front Med (Lausanne)"},{"key":"BFpr2017249_CR102","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcyt.2014.12.008","volume":"17","author":"J Galipeau","year":"2015","unstructured":"Galipeau J, Krampera M . The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. Cytotherapy 2015;17:125\u20137.","journal-title":"Cytotherapy"},{"key":"BFpr2017249_CR103","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","volume":"15","author":"P Kebriaei","year":"2009","unstructured":"Kebriaei P, Isola L, Bahceci E et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 2009;15:804\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFpr2017249_CR104","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-60761-869-0_16","volume":"677","author":"J Jiao","year":"2011","unstructured":"Jiao J, Milwid JM, Yarmush ML, Parekkadan B . A mesenchymal stem cell potency assay. Methods Mol Biol 2011;677:221\u201331.","journal-title":"Methods Mol Biol"},{"key":"BFpr2017249_CR105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294\u2013301.","journal-title":"Stem Cells"},{"key":"BFpr2017249_CR106","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/scrt442","volume":"5","author":"PR Amable","year":"2014","unstructured":"Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R . Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther 2014;5:53.","journal-title":"Stem Cell Res Ther"},{"key":"BFpr2017249_CR107","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jcyt.2014.02.008","volume":"16","author":"A Pievani","year":"2014","unstructured":"Pievani A, Scagliotti V, Russo FM et al. Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential. Cytotherapy 2014;16:893\u2013905.","journal-title":"Cytotherapy"},{"key":"BFpr2017249_CR108","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000447458","volume":"43","author":"R Schafer","year":"2016","unstructured":"Schafer R, Spohn G, Baer PC . Mesenchymal stem\/stromal cells in regenerative medicine: can preconditioning strategies improve therapeutic efficacy? Transfus Med Hemother 2016;43:256\u201367.","journal-title":"Transfus Med Hemother"},{"key":"BFpr2017249_CR109","first-page":"3945403","volume":"2017","author":"ST Ji","year":"2017","unstructured":"Ji ST, Kim H, Yun J, Chung JS, Kwon SM . Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration: from cell priming to tissue engineering. Stem Cells Int 2017;2017:3945403.","journal-title":"Stem Cells Int"},{"key":"BFpr2017249_CR110","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1089\/scd.2010.0566","volume":"21","author":"P Waszak","year":"2012","unstructured":"Waszak P, Alphonse R, Vadivel A, Ionescu L, Eaton F, Thebaud B . Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev 2012;21:2789\u201397.","journal-title":"Stem Cells Dev"},{"key":"BFpr2017249_CR111","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/cdd.2009.95","volume":"16","author":"L Danielyan","year":"2009","unstructured":"Danielyan L, Schafer R, Schulz A et al. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Cell Death Differ 2009;16:1599\u2013614.","journal-title":"Cell Death Differ"},{"key":"BFpr2017249_CR112","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/cbin.10246","volume":"38","author":"S Kang","year":"2014","unstructured":"Kang S, Kim SM, Sung JH . Cellular and molecular stimulation of adipose-derived stem cells under hypoxia. Cell Biol Int 2014;38:553\u201362.","journal-title":"Cell Biol Int"},{"key":"BFpr2017249_CR113","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nm1075","volume":"10","author":"DJ Ceradini","year":"2004","unstructured":"Ceradini DJ, Kulkarni AR, Callaghan MJ et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858\u201364.","journal-title":"Nat Med"},{"key":"BFpr2017249_CR114","doi-asserted-by":"publisher","first-page":"e33115","DOI":"10.1371\/journal.pone.0033115","volume":"7","author":"S Bruno","year":"2012","unstructured":"Bruno S, Grange C, Collino F et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 2012;7:e33115.","journal-title":"PLoS ONE"},{"key":"BFpr2017249_CR115","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/labinvest.2010.86","volume":"90","author":"AH Amin","year":"2010","unstructured":"Amin AH, Abd Elmageed ZY, Nair D et al. Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest 2010;90:985\u201396.","journal-title":"Lab Invest"},{"key":"BFpr2017249_CR116","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1089\/scd.2011.0333","volume":"21","author":"C Rota","year":"2012","unstructured":"Rota C, Imberti B, Pozzobon M et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 2012;21:1911\u201323.","journal-title":"Stem Cells Dev"},{"key":"BFpr2017249_CR117","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3727\/096368912X653246","volume":"22","author":"C Xinaris","year":"2013","unstructured":"Xinaris C, Morigi M, Benedetti V et al. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant 2013;22:423\u201336.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR118","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/jid.2011.64","volume":"131","author":"SC Heo","year":"2011","unstructured":"Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB, Kim JH . Tumor necrosis factor-alpha-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol 2011;131:1559\u201367.","journal-title":"J Invest Dermatol"},{"key":"BFpr2017249_CR119","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cvr\/cvm025","volume":"77","author":"Z Pasha","year":"2008","unstructured":"Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M . Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008;77:134\u201342.","journal-title":"Cardiovasc Res"},{"key":"BFpr2017249_CR120","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3727\/096368913X667510","volume":"23","author":"Y Tang","year":"2014","unstructured":"Tang Y, Cai B, Yuan F et al. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant 2014;23:1279\u201391.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR121","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1423-0127-16-74","volume":"16","author":"Y Yao","year":"2009","unstructured":"Yao Y, Zhang F, Wang L et al. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. J Biomed Sci 2009;16:74.","journal-title":"J Biomed Sci"},{"key":"BFpr2017249_CR122","first-page":"3472","volume":"125","author":"J Zhang","year":"2012","unstructured":"Zhang J, Chen GH, Wang YW et al. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton\u2019s Jelly mesenchymal stem cells after myocardial infarction. Chin Med J (Engl) 2012;125:3472\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"BFpr2017249_CR123","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1517\/14712598.2013.782390","volume":"13","author":"R Najafi","year":"2013","unstructured":"Najafi R, Sharifi AM . Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther 2013;13:959\u201372.","journal-title":"Expert Opin Biol Ther"},{"key":"BFpr2017249_CR124","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1620\/tjem.220.139","volume":"220","author":"X Cui","year":"2010","unstructured":"Cui X, Wang H, Guo H et al. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med 2010;220:139\u201347.","journal-title":"Tohoku J Exp Med"},{"key":"BFpr2017249_CR125","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/stem.1976","volume":"33","author":"J Beegle","year":"2015","unstructured":"Beegle J, Lakatos K, Kalomoiris S et al. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells 2015;33:1818\u201328.","journal-title":"Stem Cells"},{"key":"BFpr2017249_CR126","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1359-6101(03)00059-5","volume":"14","author":"RB Goodman","year":"2003","unstructured":"Goodman RB, Pugin J, Lee JS, Matthay MA . Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523\u201335.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFpr2017249_CR127","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","volume":"11","author":"K Kurozumi","year":"2005","unstructured":"Kurozumi K, Nakamura K, Tamiya T et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005;11:96\u2013104.","journal-title":"Mol Ther"},{"key":"BFpr2017249_CR128","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","volume":"44","author":"CT van Velthoven","year":"2013","unstructured":"van Velthoven CT, Sheldon RA, Kavelaars A et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013;44:1426\u201332.","journal-title":"Stroke"},{"key":"BFpr2017249_CR129","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jcp.21948","volume":"222","author":"T Tenzen","year":"2010","unstructured":"Tenzen T, Zembowicz F, Cowan CA . Genome modification in human embryonic stem cells. J Cell Physiol 2010;222:278\u201381.","journal-title":"J Cell Physiol"},{"key":"BFpr2017249_CR130","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","volume":"33","author":"M Rojas","year":"2005","unstructured":"Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145\u201352.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFpr2017249_CR131","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jcyt.2017.06.004","volume":"19","author":"B Reyes","year":"2017","unstructured":"Reyes B, Coca MI, Codinach M et al. Assessment of biodistribution using mesenchymal stromal cells: algorithm for study design and challenges in detection methodologies. Cytotherapy 2017;19:1060\u20139.","journal-title":"Cytotherapy"},{"key":"BFpr2017249_CR132","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3727\/096368915X689640","volume":"25","author":"WS Park","year":"2016","unstructured":"Park WS, Sung SI, Ahn SY et al. Optimal timing of mesenchymal stem cell therapy for neonatal intraventricular hemorrhage. Cell Transplant 2016;25:1131\u201344.","journal-title":"Cell Transplant"},{"key":"BFpr2017249_CR133","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/pr.2012.71","volume":"72","author":"ES Kim","year":"2012","unstructured":"Kim ES, Ahn SY, Im GH et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012;72:277\u201384.","journal-title":"Pediatr Res"},{"key":"BFpr2017249_CR134","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1161\/CIRCULATIONAHA.108.843680","volume":"120","author":"T Deuse","year":"2009","unstructured":"Deuse T, Peter C, Fedak PW et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009;120:S247\u201354.","journal-title":"Circulation"},{"key":"BFpr2017249_CR135","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/nn.3163","volume":"15","author":"Z Kokaia","year":"2012","unstructured":"Kokaia Z, Martino G, Schwartz M, Lindvall O . Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci 2012;15:1078\u201387.","journal-title":"Nat Neurosci"},{"key":"BFpr2017249_CR136","doi-asserted-by":"publisher","first-page":"e51253","DOI":"10.1371\/journal.pone.0051253","volume":"8","author":"V Donega","year":"2013","unstructured":"Donega V, van Velthoven CT, Nijboer CH et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS ONE 2013;8:e51253.","journal-title":"PLoS ONE"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017249","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:37Z","timestamp":1684616617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":136,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFpr2017249"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.249","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"assertion":[{"value":"25 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Won Soon Park and Yun Sil Chang declare potential conflicts of interest arising from a filed or issued patent titled \u201cComposition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells\u201d and \u201cMethod of treating lung diseases using cells separated or proliferated from umbilical cord blood\u201d as coinventors, not as patentees.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}